What a new study says about smoking and trigeminal neuralgia

Smoking is the act of inhaling and exhaling smoke from burning tobacco, exposing the body to nicotine and a wide range of harmful chemicals. It is widely recognised as a leading cause of serious health conditions such as heart disease, cancer, and respiratory illness, but its effects extend beyond these well-known risks. Smoking can also influence the nervous system and the function of blood vessels, potentially altering how pain is triggered and experienced within the body. One condition where this interaction may be particularly significant is trigeminal neuralgia, a chronic disorder that affects the trigeminal nerve- cranial nerve V- (as depicted in Figure 1) responsible for facial sensation. This condition is characterised by sudden, intense bursts of facial pain, often described as an electric shock, which can be triggered by simple everyday actions such as speaking, eating, or even a light touch. Together, these factors highlight a possible and important link between smoking and the development or severity of trigeminal neuralgia.

Recent research has begun to uncover this connection in more detail, offering new insights into how smoking may shape the course of the condition. In patients undergoing microvascular decompression surgery, smokers were found to develop trigeminal neuralgia at a younger age than non-smokers and were more likely to experience pain across multiple branches of the nerve. This suggests a broader spread of symptoms and potentially a more complex form of the disorder. Outcomes after surgery also appeared to differ, with smokers less likely to remain free from pain in the long term without medication. However, an encouraging finding emerged for those who had stopped smoking at least six months before surgery, as their recovery resembled that of individuals who had never smoked. This raises the possibility that quitting smoking could meaningfully improve treatment outcomes.

The reasons behind these patterns are likely to be multifaceted, involving both behavioural and biological influences. Smoking increases the frequency of oral movements, which may trigger pain episodes more often in people with trigeminal neuralgia. At the same time, it is known to affect the structure and function of blood vessels in the brain and may alter the protective covering of nerves, making them more sensitive to pressure or irritation. Although visible nerve compression did not differ greatly between smokers and non-smokers, subtle changes at a microscopic level could still intensify symptoms and limit recovery. Age also appears to play an important role, as younger patients tend to have poorer surgical outcomes, and smokers in the study were generally younger at the onset of symptoms. Altogether, these findings paint a compelling picture of how smoking may not only contribute to the earlier development of trigeminal neuralgia but also influence its severity and response to treatment, reinforcing the value of smoking cessation as part of patient care.

Written by Maria Kahloon

Related articles: Genes related to excessive smoking / Smoking cessation